Journals / The Anatolian Journal of Cardiology / 2022 / Cilt: 26 - Sayı: 5

Does Dexmedetomidine Reduce the Risk of Atrial Fibrillation and Stroke After Adult Cardiac Surgery? A Systematic Review and Meta-analysis of Randomized Controlled Trials

Pages
354–365
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

But there was no significant difference in the incidence of stroke, mechanical ventilation duration, intensive care unit length of stay, hospital length of stay, and mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:gery with increased stroke complications and mortality.
📊
Key Findings & Data:Results: Eighteen trials with a total of 2933 patients were enrolled in the meta-analyses.
💡
Conclusion & Impact:But there was no significant difference in the incidence of stroke, mechanical ventilation duration, intensive care unit length of stay, hospital length of stay, and mortality.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

gery with increased stroke complications and mortality. Although dexmedetomidine is thought to prevent postoperative atrial fibrillation and stroke because of its sympatholytic and anti-inflammatory properties, data from different studies show the effect of dexmedetomidine on postoperative atrial fibrillation and stroke uncertain in adult patients with cardiac surgery. Methods: A database including EMBASE, PubMed, and Cochrane CENTRAL was searched for randomized controlled trials comparing dexmedetomidine with placebo or other anesthetic drugs in adult cardiac surgery. The primary outcome was the incidence of postoperative atrial fibrillation. The secondary outcomes were the incidence of postoperative stroke, mechanical ventilation duration, intensive care unit length of stay, hospital length of stay, and mortality. Results: Eighteen trials with a total of 2933 patients were enrolled in the meta-analyses. Compared with controls, dexmedetomidine significantly reduced the incidence of postoperative atrial fibrillation [odds ratio, 0.82; 95% CI, 0.69-0.98; P=.03]. There was no significant difference between groups in stroke (odds ratio, 1.36; 95% CI, 0.59-3.16; P=.47), mechanical ventilation duration [weighted mean difference, −0.17; 95% CI, −0.35 to 0.14; P=.39], intensive care unit length of stay (weighted mean difference, −0.03; 95% CI, −0.93 to 0.87; P=.95), hospital length of stay (weighted mean difference, −0.04; 95% CI, −0.40 to 0.32; P=.83) and mortality (odds ratio, 0.72; 95% CI, 0.32-1.60; P=.42). Conclusion: Perioperative dexmedetomidine reduced the incidence of postoperative atrial fibrillation in adult patients undergoing cardiac surgery. But there was no significant difference in the incidence of stroke, mechanical ventilation duration, intensive care unit length of stay, hospital length of stay, and mortality.

🔖

Cite This Article

JING, C., LIN, L., ZHOU, T., LI, Y. L., FU, Y., GAO, M. Q. (2022). Does Dexmedetomidine Reduce the Risk of Atrial Fibrillation and Stroke After Adult Cardiac Surgery? A Systematic Review and Meta-analysis of Randomized Controlled Trials. The Anatolian Journal of Cardiology, Cilt: 26 - Sayı: 5, 354–365. https://ajindex.com/articles/414193

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Çelik E, Çora A, Karadem KB. Are preoperative neutrophil/ lymphocyte, platelet/lymphocyte, and platelet/neutrophil ratios markers in new-onset atrial fibrillationafter coronary artery bypass grafting? CardioVasc Surg Int. 2020
  2. 7(3):113-120. [CrossRef] 2. Kosmidou I, Chen S, Kappetein AP, et al. New-onset atrial fibrillation After PCI or CABG for left main disease. J Am Coll Cardiol. 2018
  3. 71(7):739-748. [CrossRef] 3. Rezaei Y, Peighambari MM, Naghshbandi S, et al. Postoperative atrial fibrillation following cardiac surgery: from pathogenesis to potential therapies. Am J Cardiovasc Drugs. 2019
  4. 2020(20(1)):19-49. [CrossRef] 4. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021
  5. 42(5):373-498. [CrossRef] 5. Gümüş F, Şinikoğlu NS, Yektaş A, Polat A, Kayalar N, Erkalp K. Dexmedetomidine combined with narcotic anesthesia induction in coronary artery bypass graft surgery. Turk Gogus Kalp Dama. 2013
  6. 21(3):676-682. [CrossRef] 6. Liu X, Zhang K, Wang W, Xie G, Fang X. Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. Crit Care. 2016
  7. 20(1):298. [CrossRef] 7. Zi J, Fan Y, Dong C, Zhao Y, Li D, Tan Q. Anxiety administrated by dexmedetomidine to prevent new-onset of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass graft. Int Heart J. 2020
  8. 61(2):263-272. [CrossRef] 8. Turan A, Duncan A, Leung S, et al. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. Lancet. 2020
  9. 396(10245):177-185. [CrossRef] 9. Soltani G, Jahanbakhsh S, Tashnizi MA, et al. Effects of dexmedetomidine on heart arrhythmia prevention in off-pump coronary artery bypass surgery: a randomized clinical trial. Electron Phys. 2017
  10. 9(10):5578-5587. [CrossRef] 10. Liu X, Zhang K, Wang W, et al. Dexmedetomidine versus propofol sedation improves sublingual microcirculation after cardiac surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2016
  11. 30(6):1509-1515. [CrossRef] 11. Djaiani G, Silverton N, Fedorko L, et a